NCT06694012View on ClinicalTrials.gov

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

March 31, 2050

Study Completion Date

March 31, 2050

Conditions
Type 2 Diabetes Mellitus (T2DM)Type 2 DiabetesDiabetes MellitusHypertensionHyperglycemiaHyperlipidemiaDyslipidemiaHyperuricemia or GoutHyperuricemia, GoutObesityObesity/EpidemiologyObesity, AbdominalCentral ObesityVisceral FatChronic Kidney Disease(CKD)AtherosclerosisMetabolic SyndromeHepatic SteatosisInsulin Sensitivity/Resistance
Trial Locations (1)

5938324

RECRUITING

The Ohtori Health Promotion Center, Sakai

All Listed Sponsors
collaborator

The Ministry of Education, Culture, Sports, Science and Technology, Japan

UNKNOWN

lead

Osaka Metropolitan University

OTHER